Mansco Perry III bought $21k of OAK-PA
director at Brookfield Oaktree Holdings, LLC. 1,000 shares at an average of $20.70, traded Nov 21, 2023, filed Nov 22, 2023.
Score components
- +15RoleDirector
- 0Trade size$21k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +10Price context6% above the 52-week low
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001965835-23-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 21, 2023 | POpen-market purchase Series A Preferred | +1,000 | $20.70 | $21k | 1,000 | Nov 22, 2023 |
Related signals
Other insiders at Brookfield Oaktree Holdings, LLC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | OAK-PAbuy Brookfield Oaktree Holdings, LLC | Steven J Gilbert director | $28k 1,354 shares | +7% | |
| 35Weak | OAK-PAsell Brookfield Oaktree Holdings, LLC | Mansco Perry III director | $22k 1,000 shares | -100% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.